» Articles » PMID: 29669277

Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy

Overview
Journal Cell Rep
Publisher Cell Press
Date 2018 Apr 19
PMID 29669277
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The microtubule-associated protein tau regulates myriad neuronal functions, such as microtubule dynamics, axonal transport and neurite outgrowth. Tauopathies are neurodegenerative disorders characterized by the abnormal metabolism of tau, which accumulates as insoluble neuronal deposits. The adult human brain contains equal amounts of tau isoforms with three (3R) or four (4R) repeats of microtubule-binding domains, derived from the alternative splicing of exon 10 (E10) in the tau transcript. Several tauopathies are associated with imbalances of tau isoforms, due to splicing deficits. Here, we used a trans-splicing strategy to shift the inclusion of E10 in a mouse model of tauopathy that produces abnormal excess of 3R tau. Modulating the 3R/4R ratio in the prefrontal cortex led to a significant reduction of pathological tau accumulation concomitant with improvement of neuronal firing and reduction of cognitive impairments. Our results suggest promising potential for the use of RNA reprogramming in human neurodegenerative diseases.

Citing Articles

CELF2 promotes tau exon 10 inclusion via hinge domain-mediated nuclear condensation.

Li X, Syed I, Zhang Z, Adhikari R, Tang D, Ko S bioRxiv. 2024; .

PMID: 39553957 PMC: 11566031. DOI: 10.1101/2024.11.02.621395.


RNA exon editing: Splicing the way to treat human diseases.

Doi A, Delaney C, Tanner D, Burkhart K, Bell R Mol Ther Nucleic Acids. 2024; 35(3):102311.

PMID: 39281698 PMC: 11401238. DOI: 10.1016/j.omtn.2024.102311.


Protein isoform-centric therapeutics: expanding targets and increasing specificity.

Kjer-Hansen P, Phan T, Weatheritt R Nat Rev Drug Discov. 2024; 23(10):759-779.

PMID: 39232238 DOI: 10.1038/s41573-024-01025-z.


The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.

Buchholz S, Zempel H Alzheimers Dement. 2024; 20(5):3606-3628.

PMID: 38556838 PMC: 11095451. DOI: 10.1002/alz.13784.


Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice.

Facal C, Bessone I, Muniz J, Pereyra A, Pedroncini O, Paez-Paz I Mol Ther. 2024; 32(4):1080-1095.

PMID: 38310353 PMC: 11163272. DOI: 10.1016/j.ymthe.2024.01.033.